Sign in
4

Changes in Ownership

ATOSSA THERAPEUTICS, INC. Filed Acc 0001615774-19-000645

Options or other derivatives

  • President & CEO acquired 2,300,000 shares (grant or award)
  • President & CEO returned 2,300,000 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
QUAY STEVEN C President & CEO 2019-01-13 Returned to the company · Stock Option (Right to Buy) −2,300,000 0 D
QUAY STEVEN C President & CEO 2019-01-13 Grant or award · Stock Option (Right to Buy) +2,300,000 2,300,000 D
Loading xslF345X03/s115379_form4.xml…